SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-066530
Filing Date
2014-11-10
Accepted
2014-11-10 16:32:53
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v393002_10q.htm 10-Q 270168
2 EXHIBIT 31.1 v393002_ex31-1.htm EX-31.1 9482
3 EXHIBIT 31.2 v393002_ex31-2.htm EX-31.2 9479
4 EXHIBIT 32.1 v393002_ex32-1.htm EX-32.1 3959
5 EXHIBIT 32.2 v393002_ex32-2.htm EX-32.2 3944
  Complete submission text file 0001144204-14-066530.txt   1877760

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT plx-20140930.xml EX-101.INS 141688
7 XBRL TAXONOMY EXTENSION SCHEMA plx-20140930.xsd EX-101.SCH 18521
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plx-20140930_cal.xml EX-101.CAL 36124
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plx-20140930_def.xml EX-101.DEF 58684
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE plx-20140930_lab.xml EX-101.LAB 320000
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plx-20140930_pre.xml EX-101.PRE 136523
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 141209118
SIC: 2836 Biological Products, (No Diagnostic Substances)